CoChat

PIB binding in aged primate brain: Enrichment of high-affinity sites in humans with Alzheimer's disease

Open access
Rosen, Rebecca F., Walker, Lary C., LeVine, Harry · 2011 · Neurobiology of Aging
Cited by 97

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Abstract

Aged nonhuman primates accumulate large amounts of human-sequence amyloid β (Aβ) in the brain, yet they do not manifest the full phenotype of Alzheimer’s disease (AD). To assess the biophysical properties of Aβ that might govern its pathogenic potential in humans and nonhuman primates, we incubated the benzothiazole imaging agent Pittsburgh compound B (PIB) with cortical tissue homogenates from normal aged humans, humans with AD, and from aged squirrel monkeys, rhesus monkeys, and chimpanzees with cerebral Aβ-amyloidosis. Relative to humans with AD, high-affinity PIB binding is markedly reduced in cortical extracts from aged nonhuman primates containing levels of insoluble Aβ similar to those in AD. The high-affinity binding of PIB may be selective for a pathologic, human-specific conformation of multimeric Aβ, and thus could be a useful experimental tool for clarifying the unique predisposition of humans to Alzheimer’s disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.neurobiolaging.2009.02.011

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 14 references

Research works printed but not linked: 29

  1. Arriagada, 1992, Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease, Neurology, 42, 1681, 10.1212/WNL.42.9.1681 · DOI · Paper page
  2. Bacskai, 2007, Molecular imaging with Pittsburgh Compound B confirmed at autopsy: a case report, Arch. Neurol., 64, 431, 10.1001/archneur.64.3.431 · DOI · Paper page
  3. Chien, 2004, Emerging principles of conformation-based prion inheritance, Annu. Rev. Biochem., 73, 617, 10.1146/annurev.biochem.72.121801.161837 · DOI · Paper page
  4. Collinge, 2007, A general model of prion strains and their pathogenicity, Science, 318, 930, 10.1126/science.1138718 · DOI · Paper page
  5. Dodart, 2005, Overview on rodent models of Alzheimer's disease, Curr. Protoc. Neurosci., 10.1002/0471142301.ns0922s33 · DOI · Paper page
  6. Elfenbein, 2007, Cerebral beta-amyloid angiopathy in aged squirrel monkeys, Histol. Histopathol., 22, 155
  7. Fodero-Tavoletti, 2007, In vitro characterization of Pittsburgh Compound-B binding to Lewy bodies, J. Neurosci., 27, 10365, 10.1523/JNEUROSCI.0630-07.2007 · DOI · Paper page
  8. Giannakopoulos, 2007, Assessing the cognitive impact of Alzheimer disease pathology and vascular burden in the aging brain: the Geneva experience, Acta Neuropathol. (Berl.), 113, 1, 10.1007/s00401-006-0144-y · DOI · Paper page
  9. Hardy, 2002, The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics, Science, 297, 353, 10.1126/science.1072994 · DOI · Paper page
  10. Hasegawa, 1999, Interaction between A beta(1–42) and A beta(1–40) in Alzheimer's beta-amyloid fibril formation in vitro, Biochemistry, 38, 15514, 10.1021/bi991161m · DOI · Paper page
  11. Klunk, 2003, The binding of 2-(4′-methylaminophenyl)benzothiazole to postmortem brain homogenates is dominated by the amyloid component, J. Neurosci., 23, 2086, 10.1523/JNEUROSCI.23-06-02086.2003 · DOI · Paper page
  12. Klunk, 2005, Binding of the positron emission tomography tracer Pittsburgh Compound-B reflects the amount of amyloid-beta in Alzheimer's disease brain but not in transgenic mouse brain, J. Neurosci., 25, 10598, 10.1523/JNEUROSCI.2990-05.2005 · DOI · Paper page
  13. Klunk, 2004, Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B, Ann. Neurol., 55, 306, 10.1002/ana.20009 · DOI · Paper page
  14. Kuo, 2001, Comparative analysis of amyloid-beta chemical structure and amyloid plaque morphology of transgenic mouse and Alzheimer's disease brains, J. Biol. Chem., 276, 12991, 10.1074/jbc.M007859200 · DOI · Paper page
  15. LeVine, 2008, Molecular polymorphism of Abeta in Alzheimer's disease, Neurobiol. Aging
  16. Makarava, 2008, The same primary structure of the prion protein yields two distinct self-propagating states, J. Biol. Chem., 283, 15988, 10.1074/jbc.M800562200 · DOI
  17. Mathis, 2004, Imaging beta-amyloid plaques and neurofibrillary tangles in the aging human brain, Curr. Pharm. Des., 10, 1469, 10.2174/1381612043384772 · DOI · Paper page
  18. Noda, 2008, Amyloid imaging in aged and young macaques with [11C]PIB and [18F]FDDNP, Synapse, 62, 472, 10.1002/syn.20508 · DOI · Paper page
  19. Nordberg, 2008, Amyloid plaque imaging in vivo: current achievement and future prospects, Eur. J. Nucl. Med. Mol. Imag., 35, S46, 10.1007/s00259-007-0700-2 · DOI
  20. Otvos, 1993, Human and rodent Alzheimer beta-amyloid peptides acquire distinct conformations in membrane-mimicking solvents, Eur. J. Biochem., 211, 249, 10.1111/j.1432-1033.1993.tb19893.x · DOI · Paper page
  21. Rosen, 2008, Tauopathy with paired helical filaments in an aged chimpanzee, J. Comp. Neurol., 509, 259, 10.1002/cne.21744 · DOI · Paper page
  22. Serdons, 2009, Synthesis of 18F-labelled 2-(4′-fluorophenyl)-1,3-benzothiazole and evaluation as amyloid imaging agent in comparison with [11C]PIB, Bioorg. Med. Chem. Lett., 19, 602, 10.1016/j.bmcl.2008.12.069 · DOI
  23. Svedberg, 2008, [(11)C]PIB-amyloid binding and levels of Abeta40 and Abeta42 in postmortem brain tissue from Alzheimer patients, Neurochem. Int., 54, 347, 10.1016/j.neuint.2008.12.016 · DOI
  24. Toyama, 2005, PET imaging of brain with the beta-amyloid probe, [11C]6-OH-BTA-1, in a transgenic mouse model of Alzheimer's disease, Eur. J. Nucl. Med. Mol. Imag., 32, 593, 10.1007/s00259-005-1780-5 · DOI
  25. Vinters, 1996, Brain parenchymal and microvascular amyloid in Alzheimer's disease, Brain Pathol., 6, 179, 10.1111/j.1750-3639.1996.tb00799.x · DOI · Paper page
  26. Walker, 2000, Apolipoprotein E4 promotes the early deposition of Abeta42 and then Abeta40 in the elderly, Acta Neuropathol., 100, 36, 10.1007/s004010051190 · DOI
  27. Ye, 2006, Characterisation of the binding of amyloid imaging tracers to rodent Abeta fibrils and rodent-human Abeta co-polymers, Biochem. Biophys. Res. Commun., 347, 669, 10.1016/j.bbrc.2006.06.126 · DOI
  28. Ye, 2005, Delineation of positron emission tomography imaging agent binding sites on beta-amyloid peptide fibrils, J. Biol. Chem., 280, 23599, 10.1074/jbc.M501285200 · DOI · Paper page
  29. Ye, 2008, In vitro high affinity alpha-synuclein binding sites for the amyloid imaging agent PIB are not matched by binding to Lewy bodies in postmortem human brain, J. Neurochem., 105, 1428, 10.1111/j.1471-4159.2008.05245.x · DOI · Paper page

Cited by

See all 97

Metadata

Authors
Rosen, R. F., Walker, L. C., & LeVine, H.
Venue
Neurobiology of Aging
Publisher
Elsevier BV
Published
2011-02
Volume
32
Issue
2
Pages
223-234
ISSN
0197-4580 (ISSN-L)
OpenAlex
W2017622907
Cited by
97
References
14
FWCI
7.09
Type
journal article
Language
en
Open access
green
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: PIB binding in aged primate brain: Enrichment of high-affinity sites in humans with Alzheimer's disease. https://app.cochat.ai/papers/10.1016/j.neurobiolaging.2009.02.011
The paper
Rosen, R. F., Walker, L. C., & LeVine, H. (2011). PIB binding in aged primate brain: Enrichment of high-affinity sites in humans with Alzheimer's disease. Neurobiology of Aging. https://doi.org/10.1016/j.neurobiolaging.2009.02.011

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.